2024. Quality of Life in Patients with Metastatic or Unresectable Melanoma: Is Monotherapy with Nivolumab Preferred Over Combination Therapy?. Revista Médica de Trujillo. 19, 3 (set. 2024), 092–097. DOI:https://doi.org/10.17268/rmt.2024.v19i3.6141.